Small biotechs dominate in microbiome-targeted therapies
27 April, 2018With smaller biotech companies dominating the pipeline for microbiome-targeted therapeutics, large pharma firms are eager to jump on the bandwagon.
New additive biomanufacturing centre launched
26 April, 2018The Australian Research Council has launched a new training centre focused on developing next-generation biomanufacturing technologies.
Antibody-based lung fibrosis therapy gets a redesign
19 April, 2018AdAlta has announced major improvements to the design of its preclinical therapy for lung fibrosis which have enhanced the drug's potency and extended its half-life.
New initiative to propel MTP SMEs
18 April, 2018The SME Strategic Innovation Initiative will help Australian medical technology and pharmaceutical companies better prepare themselves to engage with multinational companies.
Australia's biotech boom to continue
16 April, 2018The Australian life sciences and biotech industry is witnessing a resurgence in activity, which is expected to continue over the next 12 months.
ReCell saves skin, reduces treatment costs for burn victims
12 April, 2018AVITA Medical has conducted a pivotal clinical trial demonstrating the effectiveness of its ReCell Autologous Cell Harvesting Device in the treatment of second-degree burns.
CWE SAR-1000 Small Animal Ventilator with SAR-COMM software package
12 April, 2018The SAR-1000 Small Animal Ventilator, from CWE, offers a simple and intuitive interface which can be used in conjunction with a variety of different small animals. It delivers respiratory parameters through the use of sensors for airflow and pressure.
Clinical study commences for brain cancer drug
11 April, 2018Kazia Therapeutics' small molecule inhibitor is being developed to treat glioblastoma multiforme — the most common and aggressive form of primary brain cancer.
Phospholipid formulation found to relieve PMS
10 April, 2018A clinical study has indicated the positive effects of Lipogen PMS, a natural phospholipid formulation, in treating and relieving premenstrual syndrome (PMS) symptoms.
Immutep enters clinical trial collaboration, raises $6.85m
21 March, 2018The clinical trial will evaluate the combination of Immutep's lead immunotherapy product candidate with MSD's anti-PD-1 therapy in several different solid tumours.
Skin regeneration trial commences in China
20 March, 2018AVITA Medical has announced the commencement of a clinical trial of its ReCell regenerative medicine technology in the treatment of second-degree burns in China.
Liver inflammation reduced in NASH patients
14 March, 2018Biopharmaceutical company Immuron has announced a new treatment for LPS-related inflammation, based around its development drug IMM-124E.
Biotech spin-off brings together microbes and genomics
13 March, 2018Newly established biotechnology company Microomics has a speciality in metagenomics — the complete genomic analysis of a sample.
Modular hearing aids: functional, rechargeable, beautiful
12 March, 2018A Melbourne researcher has helped design what is claimed to be the world's first modular hearing aid — a breakthrough that took 130 prototypes to get right.
Report questions SA's GM crop ban
09 March, 2018The moratorium on genetically modified crops in South Australia does not deliver price premiums to any farmer in the state, according to market analysis company Mecardo.
